Express Scripts, which recently completed its acquisition of WellPoint's NextRx, bolstered its cash on hand this year from $530.7 million in January to $3.9 billion at the end of September. "Express Scripts has completed several acquisitions in the last decade, and is well prepared and ready to succeed," CEO George Paz said.

Related Summaries